Lupin gets nod to raise Rs 7,500 crore through issue of securities

27 Jul 2015 Evaluate

Lupin has received its shareholders approval to raise up to Rs 7,500 crore through issue of securities. The shareholders also approved reappointment of Desh Bandhu Gupta as Executive Chairman of the company for five years with effect from January 1, 2016. The company has already received its board nod for the same last month.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products.

Lupin Share Price

2132.65 -14.95 (-0.70%)
28-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1331.80
Zydus Lifesciences 896.60
Lupin 2132.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×